Lantern Pharma Unveils Innovative AI-Powered Module to Improve the Precision, Cost and Timelines of Antibody-Drug Conjugate (ADC) Development for Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. ENOV
6. AON
7. AZN
8. AAPL
9. BLSM
10. GPRO

Go back to Lantern Pharma Unveils Innovative AI-Powered Module to Improve the Precision, Cost and Timelines of Antibody-Drug Conjugate (ADC) Development for Cancer
(NASDAQ: LTRN) Delayed: 2.00 -0.03 (1.48%)
Previous Close $2.03    52 Week High $ 
Open $2.00    52 Week Low $ 
Day High $2.14    P/E N/A 
Day Low $1.97    EPS $ 
Volume 139,241